These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 11425842)
1. Ovarian and endometrial function during hormonal contraception. ESHRE Capri Workshop Group Hum Reprod; 2001 Jul; 16(7):1527-35. PubMed ID: 11425842 [TBL] [Abstract][Full Text] [Related]
2. Hormonal contraception and ovarian pathology. Crosignani PG; Vegetti W; Bianchedi D Eur J Contracept Reprod Health Care; 1997 Dec; 2(4):207-11. PubMed ID: 9678075 [TBL] [Abstract][Full Text] [Related]
3. Noncontraceptive health benefits of oral steroidal contraceptives. Mishell DR Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059 [TBL] [Abstract][Full Text] [Related]
4. [Oral contraception and its beneficial gynecological effects]. Belaisch J; Hommais-loufrani B Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188 [TBL] [Abstract][Full Text] [Related]
5. [Oral contraception: disadvantages of estrogen reduction]. Denis C Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238 [TBL] [Abstract][Full Text] [Related]
6. [Additional non-contraceptive effects of contraception: CNGOF Contraception Guidelines]. Amat L; Bulach A; Leclercq M; Mesrine S; Scheffler F; Sperandeo D; Scheffler M Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):883-888. PubMed ID: 30414725 [TBL] [Abstract][Full Text] [Related]
7. [Hormonal contraception]. Van Cauwenberge JR Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074 [TBL] [Abstract][Full Text] [Related]
8. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study. Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920 [TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive health benefits: perception versus reality. Kaunitz AM Contraception; 1999 Jan; 59(1 Suppl):29S-33S. PubMed ID: 10342094 [TBL] [Abstract][Full Text] [Related]
15. [Oral contraceptives and endometrial and ovarian carcinomas]. Medl M Gynakol Geburtshilfliche Rundsch; 1998; 38(2):105-8. PubMed ID: 9815528 [TBL] [Abstract][Full Text] [Related]
16. The state of hormonal contraception today: established and emerging noncontraceptive health benefits. Maguire K; Westhoff C Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S4-8. PubMed ID: 21961824 [TBL] [Abstract][Full Text] [Related]
17. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740 [TBL] [Abstract][Full Text] [Related]
18. The prevention of breast cancer through reduced ovarian steroid exposure. Spicer DV; Pike MC Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631 [TBL] [Abstract][Full Text] [Related]
19. Progestin-only oral contraception: a comprehensive review. McCann MF; Potter LS Contraception; 1994 Dec; 50(6 Suppl 1):S1-195. PubMed ID: 10226677 [TBL] [Abstract][Full Text] [Related]
20. Abnormal uterine bleeding associated with hormonal contraception. Schrager S Am Fam Physician; 2002 May; 65(10):2073-80. PubMed ID: 12046776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]